Siemens Healthineers AG

SHL1

Company Profile

  • Business description

    Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.

  • Contact

    Siemensstrasse 3
    ForchheimBY91301
    DEU

    T: +49 9131843385

    https://www.siemens-healthineers.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2026

    Employees

    74,000

Stocks News & Analysis

stocks

AI driving growth for ASX tech share

ASX tech share raises funds to facilitate customer AI spend.
stocks

OpenAI is going public as the worst value among its peers

Investors are paying a steep price relative to the underlying business quality, PitchBook research says.
stocks

Wide moat healthcare leader remains undervalued

ASX healthcare giant expected to see uptick in demand from emerging markets.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,740.8016.50-0.19%
CAC 408,199.2918.95-0.23%
DAX 4024,616.22142.83-0.58%
Dow JONES (US)50,786.0180.77-0.16%
FTSE 10010,373.205.150.05%
HKSE24,657.06304.89-1.22%
NASDAQ25,929.66220.230.86%
Nikkei 22563,990.6533.95-0.05%
NZX 50 Index13,074.2436.000.28%
S&P 5007,405.7321.990.30%
S&P/ASX 2008,521.4012.10-0.14%
SSE Composite Index3,959.3468.40-1.70%

Market Movers